Paper Details

  1. Home
  2. Paper Details

Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures.

Author: HammondE J, KarasB J, MarquardtK, MurphyJ V, RamsayR E, WilderB J

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.

Overview

Valproate and phenytoin were both effective in preventing seizure recurrence in newly diagnosed epileptic patients. Valproate was more effective than phenytoin, with similar mild side effects and laboratory abnormalities.
Paper Details　
Original Abstract of the Article :
Sixty-one newly diagnosed epileptic patients with generalized tonic-clonic, clonic, or tonic seizures were randomly allocated to treatment with valproate (VPA) and phenytoin (PHT). After 6 months, both drugs had been effective in preventing recurrence of seizures. Seventy-three percent of patients r...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1212/wnl.33.11.1474

データ提供：米国国立医学図書館（NLM）

Valproic Acid vs. Phenytoin for Newly Diagnosed Tonic-Clonic Seizures

Navigating the vast desert of epilepsy treatment can be daunting, with many different paths and potential challenges. This research examines the effectiveness of two commonly used antiepileptic drugs, valproic acid (VPA) and phenytoin (PHT), for newly diagnosed tonic-clonic seizures. This study, like a well-equipped caravan venturing into the desert, sought to compare the efficacy and safety of these two treatments.

The researchers, like seasoned travelers, carefully observed and documented the effects of each medication, seeking to find the most effective and safest route for patients. They found that both VPA and PHT were effective in preventing seizure recurrence, with VPA demonstrating a higher success rate.

Navigating Epilepsy Treatment

The study suggests that VPA may be a more effective option for preventing seizure recurrence, although both drugs showed significant promise. This finding offers a valuable insight for clinicians seeking to optimize treatment strategies for patients newly diagnosed with tonic-clonic seizures.

Making Informed Decisions About Epilepsy Treatment

Understanding the potential benefits and risks of different epilepsy medications is crucial for making informed decisions about treatment. It's important to work closely with a healthcare professional to find the best treatment option for your individual needs and circumstances. This research offers valuable information to support these discussions and guide treatment strategies.

Dr.Camel's Conclusion

This study offers a valuable comparison of two commonly used epilepsy medications, highlighting the importance of individual patient needs and careful monitoring during treatment. While both VPA and PHT were found to be effective, the study suggests that VPA may be a more effective option for preventing seizure recurrence. This research contributes to the ongoing quest for better understanding and treatment of epilepsy, a condition that continues to impact millions worldwide.

Date :
  1. Date Completed 1983-12-17
  2. Date Revised 2019-05-14
Further Info :

Pubmed ID

6415511

DOI: Digital Object Identifier

10.1212/wnl.33.11.1474

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.